OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AU08         View EO 12866 Meetings	Received Date: 05/14/2020
Title: CY 2021 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Incentive Program (CMS-1732)
Agency/Subagency: HHS / CMS	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 07/02/2020
Legal Deadline: Statutory	Economically Significant: Yes
Publication Date: 07/13/2020	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No